SBC Medical Group Holdings Incorporated (SBC)
NASDAQ: SBC · Real-Time Price · USD
3.720
+0.060 (1.64%)
At close: Mar 6, 2026, 4:00 PM EST
3.790
+0.070 (1.88%)
After-hours: Mar 6, 2026, 4:10 PM EST

SBC Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for SBC stock has a target of 8.00, which predicts an increase of 115.05% from the current stock price of 3.72.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $8.00 $8.00 $8.00 $8.00
Change +115.05% +115.05% +115.05% +115.05%

Analyst Ratings

According to 1 stock analyst, the rating for SBC is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Mar '26
Strong Buy 1
Buy 0
Hold 0
Sell 0
Strong Sell 0
Total 1

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
BTIG
BTIG
Strong Buy
Initiates
$8
Strong Buy Initiates $8 +115.05% Mar 6, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
181.03M
from 205.42M
Decreased by -11.87%
Revenue Next Year
193.29M
from 181.03M
Increased by 6.77%
EPS This Year
0.45
from 0.48
Decreased by -7.25%
EPS Next Year
0.50
from 0.45
Increased by 11.65%
Fiscal Year FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
174.16M193.54M205.42M181.03M193.29M216.02M
Revenue Growth
-11.13%6.14%-11.87%6.77%11.76%
EPS
0.790.420.480.450.500.60
EPS Growth
--47.39%15.50%-7.25%11.65%19.19%
Forward PE
---8.317.446.24
No. Analysts ---543
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High 191.9M 204.0M
Avg 181.0M 193.3M
Low 173.9M 185.9M

Revenue Growth

Revenue Growth 202520262027
High
-6.6%
12.7%
Avg
-11.9%
6.8%
Low
-15.4%
2.7%

EPS Forecast

EPS 202520262027
High 0.51 0.53
Avg 0.45 0.50
Low 0.37 0.48

EPS Growth

EPS Growth 202520262027
High
6.6%
17.2%
Avg
-7.2%
11.7%
Low
-22.9%
7.2%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.